Microbiologics has appointed Alan Kaplan as the company’s US National Sales Manager. Reporting to Brad Pieper, Microbiologics Vice President of Sales and Marketing, Kaplan will be developing and leading the company’s sales activities in the US marketplace.

Based in St. Cloud, Minnesota, Microbiologics currently employs more than 100 people and is majority owned by local investment group, Granite Equity Partners. Pieper commented, “Microbiologics has achieved significant growth over the past six years and we continue to have aggressive plans for growth over the next six. Alan will play a critical role in realizing this goal; his extensive experience and expertise in our industry will make him a great asset to our team.”

Most recently, Kaplan was the Director of North American Sales at Applied Spectral Imaging; prior to that he held the position of Director of National Sales, Microbiology, at Thermo Fisher Scientific for over 8 years. Kaplan expressed excitement about his new role, stating, “I am pleased to be joining the Microbiologics team and collaborating with this group of dedicated professionals. The fact that this is the only company in the world focused wholly on QC microorganisms is exciting as this has been my area of expertise; I look forward to making an impact here.”

Leading the biomaterials industry in product breadth and depth, Microbiologics produces more than 900 microorganism strains in a wide range of prepared formats including live and inactivated cultures, genomic DNA/RNA extracts, synthetic nucleic acid standards and more. Chief Executive Officer, Brad Goskowicz, commented, “Microbiologics is a rapidly growing company.  In order to continue the impressive growth rates we have achieved thus far, we are strategically bringing on individuals who are at the top of their game. Given his deep knowledge of the industry and proven track record of success, Alan is a great fit for the National Sales Manager role and we are excited to have him joining our team.”